Design, Synthesis, Biological Evaluation, and Docking Study of Acetylcholinesterase Inhibitors: New Acridone-1,2,4-oxadiazole-1,2,3-triazole Hybrids
作者:Maryam Mohammadi-Khanaposhtani、Mohammad Mahdavi、Mina Saeedi、Reyhaneh Sabourian、Maliheh Safavi、Mahnaz Khanavi、Alireza Foroumadi、Abbas Shafiee、Tahmineh Akbarzadeh
DOI:10.1111/cbdd.12609
日期:2015.12
this study, novel acridone‐1,2,4‐oxadiazole‐1,2,3‐triazole hybrids were designed, synthesized, and evaluated for their acetylcholinesterase and butyrylcholinesterase inhibitory activity. Among various synthesized compounds, 10‐((1‐((3‐(4‐methoxyphenyl)‐1,2,4‐oxadiazol‐5‐yl)methyl)‐1H‐1,2,3‐triazol‐4‐yl)methyl)acridin‐9(10H)‐one 10b showed the most potent anti‐acetylcholinesterase activity (IC50 = 11.55 μm)
在这项研究中,设计,合成并评估了新的a啶酮1,2,4,恶二唑1,2,3-三唑杂合体的乙酰胆碱酯酶和丁酰胆碱酯酶抑制活性。在各种合成的化合物中,10-((1-((3-(4--甲氧基苯基)-1,2,4-恶二唑-5-基)甲基)-1 H -1,2,3-三唑-4-基)甲基)吖啶-9-(10 ħ) -酮10b中显示出最有效的抗乙酰胆碱酯酶活性(IC 50 = 11.55 μ米)是一样有效的利凡斯的明。对接结果也与体外结果高度吻合,证实了化合物10b的双重结合抑制活性。